OXYGENTA PHARMACEUTICAL
|
The Current P/E Ratio of OXYGENTA PHARMACEUTICAL is -2,158.05.
Share Price | ₹77.0 | Apr 21,2025 |
Market Cap | ₹284.9 Cr | |
Earnings-TTM | ₹-0.1 Cr | TTM-Standalone Results |
Price/Earnings | -2,158.05x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of OXYGENTA PHARMACEUTICAL
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹284.9 Cr] as on Apr 21,2025
(/) Earnings [ ₹-0.1 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ -2,158.05x ]
Thus, for OXYGENTA PHARMACEUTICAL , the investors are currently willing to pay -2,158.05 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of OXYGENTA PHARMACEUTICAL !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of OXYGENTA PHARMACEUTICAL over the last five years.
Historical PE (Price/Earnings) ratio chart of OXYGENTA PHARMACEUTICAL
PE Ratio Performance Analysis for OXYGENTA PHARMACEUTICAL
- OXYGENTA PHARMACEUTICAL 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 0.00x.
- OXYGENTA PHARMACEUTICAL 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, OXYGENTA PHARMACEUTICAL 's p/e ratio peaked in Mar2024 at 0x.
- OXYGENTA PHARMACEUTICAL 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does OXYGENTA PHARMACEUTICAL 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
OXYGENTA PHARMACEUTICAL | -0.13 | -2,158.05 | 284.9 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,486.00 | 36.43 | 418,468.0 |
DIVIS LABORATORIES LTD | 2,067.00 | 75.63 | 156,319.0 |
CIPLA LTD | 5,000.43 | 24.41 | 122,075.0 |
TORRENT PHARMACEUTICALS LTD | 1,862.00 | 59.14 | 110,125.0 |
DR REDDYS LABORATORIES LTD | 5,428.60 | 18.09 | 98,227.9 |
MANKIND PHARMA LTD | 2,050.73 | 51.98 | 106,592.0 |
ZYDUS LIFESCIENCES LTD | 4,591.80 | 18.52 | 85,051.9 |
LUPIN LTD | 2,892.10 | 31.71 | 91,719.4 |
AUROBINDO PHARMA LTD | 3,500.25 | 19.92 | 69,728.1 |
ABBOTT INDIA LTD | 1,334.46 | 49.20 | 65,655.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs OXYGENTA PHARMACEUTICAL 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | -2.00x |
Max industry PE | 75.63x |
Median industry PE | 31.71x |
Average industry PE | 34.82x |
You may also like the below Video Courses